San Diego-based Illumina (NASDAQ: [[ticker:ILMN]]), the maker of instruments for genetic analysis, said today it has sold four new Genome Analyzer machines to the Genome Institute of Singapore. Researchers there, who now have six of the machines, plan to use the tools for research of cancer and stem cells. The Singapore center counts several prominent U.S. scientists on its advisory board, including Robert Weinberg of the Whitehead Institute for Biomedical Research and MIT.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
